Marlene Fishman

664 total citations
20 papers, 520 citations indexed

About

Marlene Fishman is a scholar working on Molecular Biology, Ophthalmology and Infectious Diseases. According to data from OpenAlex, Marlene Fishman has authored 20 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Ophthalmology and 4 papers in Infectious Diseases. Recurrent topics in Marlene Fishman's work include Retinal Diseases and Treatments (5 papers), Retinal Development and Disorders (4 papers) and melanin and skin pigmentation (3 papers). Marlene Fishman is often cited by papers focused on Retinal Diseases and Treatments (5 papers), Retinal Development and Disorders (4 papers) and melanin and skin pigmentation (3 papers). Marlene Fishman collaborates with scholars based in United States and Netherlands. Marlene Fishman's co-authors include Paul E. Kilbride, Gerald A. Fishman, August F. Deutman, Alex E. Krill, John S. Read, Kenneth R. Alexander, L. P. Hutman, Maurice F. Rabb, Gerald A. Fishman and Dennis J. Mikolich and has published in prestigious journals such as Vision Research, British Journal of Ophthalmology and Infection Control and Hospital Epidemiology.

In The Last Decade

Marlene Fishman

17 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlene Fishman United States 11 284 247 107 87 57 20 520
R. Kennon Guerry United States 7 321 1.1× 211 0.9× 120 1.1× 32 0.4× 43 0.8× 9 548
P Nemet Israel 11 152 0.5× 60 0.2× 88 0.8× 19 0.2× 20 0.4× 34 328
Sigmund Blika Norway 12 445 1.6× 71 0.3× 269 2.5× 10 0.1× 8 0.1× 24 557
Antony Clarke United States 11 562 2.0× 301 1.2× 208 1.9× 78 0.9× 17 746
Maneck Nicholson India 4 143 0.5× 48 0.2× 99 0.9× 104 1.2× 31 0.5× 6 309
Mazen Al‐Essa Kuwait 12 25 0.1× 100 0.4× 94 0.9× 31 0.4× 10 0.2× 28 399
Lee K. Schwartz United States 5 241 0.8× 55 0.2× 31 0.3× 25 0.3× 12 0.2× 6 489
E. Santos-Bueso Spain 10 345 1.2× 41 0.2× 209 2.0× 89 1.0× 36 0.6× 179 560
Hyo Seok Lee South Korea 16 176 0.6× 33 0.1× 144 1.3× 7 0.1× 5 0.1× 34 679
Ramji Singh India 11 30 0.1× 49 0.2× 37 0.3× 44 0.5× 16 0.3× 52 305

Countries citing papers authored by Marlene Fishman

Since Specialization
Citations

This map shows the geographic impact of Marlene Fishman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlene Fishman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlene Fishman more than expected).

Fields of papers citing papers by Marlene Fishman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlene Fishman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlene Fishman. The network helps show where Marlene Fishman may publish in the future.

Co-authorship network of co-authors of Marlene Fishman

This figure shows the co-authorship network connecting the top 25 collaborators of Marlene Fishman. A scholar is included among the top collaborators of Marlene Fishman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlene Fishman. Marlene Fishman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fishman, Marlene, et al.. (2005). Patient Safety Tools: SARS, Smallpox, Monkeypox, and Avian Flu. PubMed. 3(3). 86–90. 1 indexed citations
2.
Fishman, Marlene, et al.. (2002). The Best Hospital Practices for Controlling Methicillin-Resistant Staphylococcus Aureus: On the Cutting Edge. Infection Control and Hospital Epidemiology. 23(2). 69–76. 54 indexed citations
3.
Fishman, Marlene, et al.. (2002). Handling of surgical instruments in a presymptomatic familial carrier of Creutzfeldt-Jakob disease. American Journal of Infection Control. 30(5). 303–306. 2 indexed citations
4.
Fishman, Marlene, et al.. (1999). Medical records contaminated with dried blood: A quality issue. American Journal of Infection Control. 27(5). 438–443. 2 indexed citations
5.
Fishman, Marlene, et al.. (1998). Prevention of Creutzfeldt-Jakob disease in health care workers: A case study. American Journal of Infection Control. 26(1). 74–79. 5 indexed citations
6.
Fishman, Marlene, et al.. (1997). NAPL: Simulator documentation. Research report, October 1992-September 1995. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 2 indexed citations
7.
Fishman, Marlene, et al.. (1992). Neurologic complications of heart transplantation in children.. PubMed. 11(5). 933–42. 33 indexed citations
8.
Kilbride, Paul E., Kenneth R. Alexander, Marlene Fishman, & Gerald A. Fishman. (1989). Human macular pigment assessed by imaging fundus reflectometry. Vision Research. 29(6). 663–674. 78 indexed citations
9.
Alexander, Kenneth R., Paul E. Kilbride, Gerald A. Fishman, & Marlene Fishman. (1987). Macular pigment and reduced foveal short-wavelength sensitivity in retinitis pigmentosa. Vision Research. 27(7). 1077–1083. 16 indexed citations
10.
Kilbride, Paul E., Marlene Fishman, Gerald A. Fishman, & L. P. Hutman. (1986). Foveal Cone Pigment Density Difference and Reflectance in Retinitis Pigmentosa. Archives of Ophthalmology. 104(2). 220–224. 26 indexed citations
11.
Stratton, Charles W. & Marlene Fishman. (1986). Topics in Clinical Microbiology: Microbial Adherence and Infection—Clinical Relevance. Infection Control. 7(3). 181–185. 2 indexed citations
12.
Kilbride, Paul E., L. P. Hutman, Marlene Fishman, & John S. Read. (1986). Foveal cone pigment density difference in the aging human eye. Vision Research. 26(2). 321–325. 65 indexed citations
13.
Fishman, Marlene, et al.. (1985). Brief Report: Needle Punctures—Documentation and Incidence Rate Calculation. Infection Control. 6(1). 35–36. 3 indexed citations
14.
Fishman, Marlene, et al.. (1985). Cost-effective regional audiovisual aids library. American Journal of Infection Control. 13(5). A35–A36.
15.
Fishman, Marlene. (1984). Preparation of audiovisual aids of infection control education. American Journal of Infection Control. 12(1). 10–13.
16.
Kilbride, Paul E., John S. Read, Gerald A. Fishman, & Marlene Fishman. (1983). Determination of human cone pigment density difference spectra in spatially resolved regions of the fovea. Vision Research. 23(12). 1341–1350. 43 indexed citations
17.
Fishman, Gerald A., et al.. (1979). Visual loss and foveal lesions in Usher's syndrome.. British Journal of Ophthalmology. 63(7). 484–488. 21 indexed citations
18.
Fishman, Gerald A., et al.. (1977). Pseudovitelliform Macular Degeneration. Archives of Ophthalmology. 95(1). 73–76. 42 indexed citations
19.
Fishman, Marlene, et al.. (1976). The Electro-oculogram in Diffuse (Familial) Drusen. Archives of Ophthalmology. 94(2). 231–233. 10 indexed citations
20.
Krill, Alex E., August F. Deutman, & Marlene Fishman. (1973). The cone degenerations. Documenta Ophthalmologica. 35(1). 1–80. 115 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026